An outbreak of acute hepatitis C among recipients of intravenous immunoglobulin

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 2, 1996, Pages 160-162

  Flora, Kenneth ^a   Schiele, Mark ^a   Benner, Kent ^a   Montanaro, Anthony ^a   Johnston, Wendy ^a   Whitham, Ruth ^a   Press, Richard ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS RNA;

AGAMMAGLOBULINEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DOSE RESPONSE; DRUG CONTAMINATION; EPIDEMIC; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; POLYRADICULITIS; PRIORITY JOURNAL; REMISSION; VIRUS TRANSMISSION;

EID: 0030020909     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63416-3     Document Type: Article

References (8)

1. Outbreak of hepatitis C associated with intravenous immunoglobulin administration-United States, October 1993-June 1994. MMWR Morb Mortal Wkly Rep 1994;43:505-9.
2. Healey CJ, Sabharwal NK, McOmish F, et al. Outbreak of acute hepatitis C following intravenous immunoglobulin therapy [Abstract]. Hepatology 1994;20(4):249A.
3. Bjoro K, Froland SS, Yun Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331:1607-11.
4. Viladomiu L, Genesca J, Esteban JI, et al. Interferon alfa in acute post-transfusion hepatitis C: A randomized, controlled trial. Hepatology 1992;15:767-9.
5. Lampertico P, Rumi MG, Romeo R, et al. A multicenter, randomized, controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994;19:19-22.
6. Jacobs L, O'Malley J, Freeman A, Ekes R. Intrathecal interferon reduces exacerbations of multiple sclerosis. Science 1981;214:1026-8.
7. IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43: 655-61.
8. Knobler RL, Panitch HS, Braheny SL, et al. Systemic alpha-interferon therapy of multiple sclerosis. Neurology 1984;34:1273-9.